Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1535, doi. 10.1111/cts.13017
- By:
- Publication type:
- Article